NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease ...

In alignment with the FDA’s draft guidance, Noom offers a robust PDURS-oriented solution tailored to support improved patient outcomes as a companion app for weight loss medications. According ...

The European Union has a plan for dealing with increasing cyberattacks against hospitals in its member countries.

like Noom or Found combines health coaching, ongoing treatment monitoring by a doctor, and prescription weight loss medication for a personalized approach accepts most major insurance plans ...

Zepbound is the newest GLP-1 medication to be approved by the Food and Drug Administration (FDA) for weight loss. It’s available only by prescription for people with a body mass index (BMI) of ...

Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect prevalence and improving lean mass preservation and ...